SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-23-000119
Filing Date
2023-11-09
Accepted
2023-11-09 08:36:04
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q carm-20230930.htm   iXBRL 10-Q 1462667
2 EX-31.1 carm-20230930xexx311.htm EX-31.1 10669
3 EX-31.2 carm-20230930xexx312.htm EX-31.2 10694
4 EX-32.1 carm-20230930xexx321.htm EX-32.1 4984
5 EX-32.2 carm-20230930xexx322.htm EX-32.2 5007
  Complete submission text file 0001485003-23-000119.txt   5984363

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT carm-20230930.xsd EX-101.SCH 48299
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT carm-20230930_cal.xml EX-101.CAL 60574
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT carm-20230930_def.xml EX-101.DEF 148027
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT carm-20230930_lab.xml EX-101.LAB 594913
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT carm-20230930_pre.xml EX-101.PRE 348574
61 EXTRACTED XBRL INSTANCE DOCUMENT carm-20230930_htm.xml XML 599835
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 231390232
SIC: 2834 Pharmaceutical Preparations